drugset
drugset / Trial / NCT03644108

Study to Evaluate the Pharmacokinetics of Mucinex 600 mg Extended-release Bi-layer Tablet in Healthy Volunteers

NCT03644108 ↗

Phase 1 Completed 30 enrolled Reckitt Benckiser Inc.
NaSingle-groupOpen-labelBasic science

Summary

Evaluate the Pharmacokinetics of Mucinex® 600 mg Extended-Release Bi-Layer Tablet in Normal Healthy Subjects

Timeline

Start
2009-06-04
Primary completion
2009-06-15
Completion
2009-06-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Guaifenesin Small molecule 600 mg —

Indications

No indication recorded.